MRX DEADLINE: Faruqi & Faruqi Reminds Marex Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 8, 2025 – MRX

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Marex To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Marex between May 16, 2024 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh […]

ACB’s 2025 Audio Description Awards Gala Announces Honorees

The American Council of the Blind (ACB) and its Audio Description Project (ADP) broadcast the 5th Annual Audio Description Awards Gala on Thursday, November 13, 2025. It was a star-studded celebration honoring excellence and innovation in audio description across popular entertainment, education, gaming, live events, and more. https://mma.prnewswire.com/media/645267/ACB_Logo.jpg The Gala recognizes the creators, platforms, and

Public Voting Opens for 1-FIND SERVICES in 2025 TechBehemoths Awards

Johnson City, TN – Public voting has officially opened for the 2025 TechBehemoths Awards, and Johnson City-based digital marketing agency 1-FIND SERVICES is inviting community support as it competes nationally in Web Design, SEO, and WordPress Development. Earlier this month, 1-FIND SERVICES earned its nomination for outstanding performance and consistent engagement on the TechBehemoths platform

Wizmo, Inc. Launches Omnis Studio Migration & Legacy App Support

Eagan, MN – Wizmo, Inc., a legacy application support and private-cloud infrastructure company, announced Omnis Studio migration and support, a service designed to help organizations keep essential Omnis applications running smoothly while preparing for future growth. The offering focuses on business continuity first, then introduces improvements such as secure remote access, steadier performance on modern

KMX ALERT: Securities Fraud Class Action Launched Against CarMax, Inc. – January 2, 2026 Deadline

NEW YORK, NY / ACCESS Newswire / November 14, 2025 / If you suffered a loss on your CarMax, Inc. (NYSE:KMX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/carmax-inc-lawsuit-submission-form?prid=177418&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

James Hardie Industries plc. (JHX) Lawsuit – Investors Urged to Contact Levi & Korsinsky Before December 23, 2025

NEW YORK, NY / ACCESS Newswire / November 14, 2025 / If you suffered a loss on your James Hardie Industries plc. (NYSE:JHX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/james-hardie-industries-plc-lawsuit-submission-form?prid=177417&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Exelixis, Inc. – EXEL

NEW YORK CITY, NY / ACCESS Newswire / November 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Exelixis, Inc. ("Exelixis" or the "Company") (NASDAQ:EXEL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Exelixis and certain of its officers and/or directors

MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm

(NASDAQ:MLTX), LOS ANGELES, Nov. 14, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the

MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm

MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm GlobeNewswire November 14, 2025 LOS ANGELES, Nov. 14, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MoonLake Immunotherapeutics (“MoonLake” or “the Company”) (NASDAQ: MLTX) for

Scroll to Top